Hancock Whitney’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Hancock Whitney's RGEN Position: Q1 2022 in Review
Hancock Whitney sold out of Repligen (RGEN) in Q1 2022, closing a stake of 10,682 shares — an estimated $2.83M sold.
Hancock Whitney first reported a position in RGEN in Q1 2014 and held it in 17 quarters. The position peaked at $4.4M in Q4 2020. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- Hancock Whitney reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- Hancock Whitney sold 10,682 Repligen shares in Q1 2022, an estimated $2.83M.
- Hancock Whitney first reported a position in Repligen in Q1 2014 and held it in 17 quarters.
- Hancock Whitney's Repligen position peaked at $4.4M in Q4 2020.
- 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on Hancock Whitney's 13F filing for Q1 2022, filed 12 May 2022.